An integrated Biobank in the Swedish Heart Failure Registry—clinomics, proteomics, transcriptomics and genomics
ESC Heart Failure · 03.03.2026 · 13 (2)
DOI: 10.1093/eschf/xvag092 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift ESC Heart Failure, online erschienen am 08.04.2026. Verfasst von Camilla Hage und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Karolinska Institutet, Stockholm S-171 64, Sweden. Hauptthemen laut MEDLINE: Biological Specimen Banks, Genomics, Heart Failure, Proteomics. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Aims
To build a comprehensive biobank integrated in the Swedish Heart Failure Registry (SwedeHF) comprising comprehensive clinomic data, proteomic, transcriptomic and genomic information in combination with clinical and diagnostic characteristics and additional ICD-code registry data.
Methods
Blood and urine samples will be biobanked at SwedeHF registration with an optional second sampling after 6 months in patients with HF attending routine clinical visits at nine hospitals with access to healthcare integrated biobanking. Circulating and urine biomarkers will be investigated by proteomic, metabolomic, transcriptomic profiling, explored with genetic data. Sample size assessments were based on the BIOSTAT-CHF cohort and doubled to fulfil all aims targeting 5000 patients.
Results
The first 1348 enrolled patients were median 72 years, 30% females, 65% HFrEF and 11% HFpEF. Median NT-proBNP was 1240 (quartile 1–3; 470–2830) pg/mL. This was comparable to the 8506 patients with an index registration in SwedeHF during 2023 with 52% HFrEF and 20% HFpEF, age 75 years, 36% females and NT-proBNP 1560 [629–3617] pg/mL.
Conclusions
We are building a high-quality detailed biobank linked to SwedeHF, the world’s largest continuous HF registry, consisting of plasma, serum, whole blood and urine samples. The Biobank will enable studies exploring underlying disease mechanisms in HF and response to HF treatment, paving the way for precision medicine and novel drug targets. It will also generate a structure for biobanking in Registry-based Randomized Controlled Trials within the national SwedeHF registry. ClinicalTrials.gov Identifier NCT06435585
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Karolinska Institutet, Stockholm S-171 64, Sweden.
- Department of Cardiology, Karolinska University Hospital, Stockholm S-171 64, Sweden.
- Departement of Public Health and Clinical Medicine, Umea University Hospital, UmeåS-901 85 Sweden.
- Department of Medical Sciences, Cardiology, Uppsala University, Uppsala S-751 85, Sweden.
- Department of Medicine, Ryhov Hospital, Jönköping S-551 85, Sweden.
- Department of Health, Medicine and Caring Sciences, Linköping University, Linköping S-581 91, Sweden.
ORCID-Profile: Camilla Hage, Christina Christersson, Cecilia Linde, Patric Karlström, Martin Magnusson, J Gustav Smith
Zitieren
APA
Hage, C., Andersson, T., Christersson, C., Linde, C., Lund, L. H., Karlström, P., Chatziapostolou, D., Dagner, V., Granström, F., Gylling, A., Jonsson, Å., Haglund, P., Högberg, J., Odenstedt, A., Viklund, U., Magnusson, M., Smith, J. G., Szabó-Söderberg, B., Östgärd Thunström, E., & Dahlström, U. (2026). An integrated Biobank in the Swedish Heart Failure Registry—clinomics, proteomics, transcriptomics and genomics. ESC Heart Failure, 13(2). https://doi.org/10.1093/eschf/xvag092
Vancouver
Hage C, Andersson T, Christersson C, Linde C, Lund LH, Karlström P, et al. An integrated Biobank in the Swedish Heart Failure Registry—clinomics, proteomics, transcriptomics and genomics. ESC Heart Failure. 2026;13(2). doi:10.1093/eschf/xvag092
BibTeX
@article{Hage2026,
author = {Hage, Camilla and Andersson, Therese and Christersson, Christina and Linde, Cecilia and Lund, Lars H and Karlström, Patric and Chatziapostolou, Dina and Dagner, Viveka and Granström, Frida and Gylling, Anette and Jonsson, Åsa and Haglund, Pernilla and Högberg, Jenny and Odenstedt, Annika and Viklund, Ulrika and Magnusson, Martin and Smith, J Gustav and Szabó-Söderberg, Barna and Östgärd Thunström, Erik and Dahlström, Ulf},
title = {An integrated Biobank in the Swedish Heart Failure Registry—clinomics, proteomics, transcriptomics and genomics},
journal = {ESC Heart Failure},
year = {2026},
volume = {13},
number = {2},
doi = {10.1093/eschf/xvag092}
}
EUVIMED